Emerging ciprofloxacin-resistant Pseudomonas aeruginosa

Nauman A. Chaudhry; Harry W. Flynn; Timothy G. Murray; Homayoun Tabandeh; Mozart O. Mello; Darlene Miller

doi:10.1016/S0002-9394(99)00196-8

Emerging ciprofloxacin-resistant Pseudomonas aeruginosa

Nauman A. Chaudhry, Harry W. Flynn, Timothy G. Murray, Homayoun Tabandeh, Mozart O. Mello, Darlene Miller

Ophthalmology

Research output: Contribution to journal › Article › peer-review

89 Scopus citations

Abstract

PURPOSE: To report a clinical series of ciprofloxacin-resistant ocular isolates of Pseudomonas aeruginosa from a tertiary care ophthalmic center.METHODS: Review of in vitro sensitivities of all ocular isolates of P. aeruginosa between July 1991 and September 1998. In vitro resistance was defined as a minimum inhibitory concentration of 4 or more μg per ml. RESULTS: Nine of 423 ocular isolates of P. aeruginosa showed in vitro resistance to ciprofloxacin. From 1991 to 1994, 0.44% (1/227) of ocular isolates were resistant to ciprofloxacin, whereas from 1995 to 1998, 4.1% (8/196) of ocular isolates showed in vitro resistance (P = .014).CONCLUSIONS: Ciprofloxacin-resistant P. aeruginosa has been identified in recent clinical ocular specimens. Ciprofloxacin resistance among ocular isolates of P. aeruginosa is a local and worldwide concern. Copyright (C) 1999 Elsevier Science Inc.

Original language	English (US)
Pages (from-to)	509-510
Number of pages	2
Journal	American journal of ophthalmology
Volume	128
Issue number	4
DOIs	https://doi.org/10.1016/S0002-9394(99)00196-8
State	Published - Oct 1999

ASJC Scopus subject areas

Ophthalmology

Access to Document

10.1016/S0002-9394(99)00196-8

Cite this

@article{25130e87d88f49669a8cc877e4e3922b,

title = "Emerging ciprofloxacin-resistant Pseudomonas aeruginosa",

abstract = "PURPOSE: To report a clinical series of ciprofloxacin-resistant ocular isolates of Pseudomonas aeruginosa from a tertiary care ophthalmic center.METHODS: Review of in vitro sensitivities of all ocular isolates of P. aeruginosa between July 1991 and September 1998. In vitro resistance was defined as a minimum inhibitory concentration of 4 or more μg per ml. RESULTS: Nine of 423 ocular isolates of P. aeruginosa showed in vitro resistance to ciprofloxacin. From 1991 to 1994, 0.44% (1/227) of ocular isolates were resistant to ciprofloxacin, whereas from 1995 to 1998, 4.1% (8/196) of ocular isolates showed in vitro resistance (P = .014).CONCLUSIONS: Ciprofloxacin-resistant P. aeruginosa has been identified in recent clinical ocular specimens. Ciprofloxacin resistance among ocular isolates of P. aeruginosa is a local and worldwide concern. Copyright (C) 1999 Elsevier Science Inc.",

author = "Chaudhry, {Nauman A.} and Flynn, {Harry W.} and Murray, {Timothy G.} and Homayoun Tabandeh and Mello, {Mozart O.} and Darlene Miller",

year = "1999",

month = oct,

doi = "10.1016/S0002-9394(99)00196-8",

language = "English (US)",

volume = "128",

pages = "509--510",

journal = "American Journal of Ophthalmology",

issn = "0002-9394",

publisher = "Elsevier USA",

number = "4",

}

TY - JOUR

T1 - Emerging ciprofloxacin-resistant Pseudomonas aeruginosa

AU - Chaudhry, Nauman A.

AU - Flynn, Harry W.

AU - Murray, Timothy G.

AU - Tabandeh, Homayoun

AU - Mello, Mozart O.

AU - Miller, Darlene

PY - 1999/10

Y1 - 1999/10

N2 - PURPOSE: To report a clinical series of ciprofloxacin-resistant ocular isolates of Pseudomonas aeruginosa from a tertiary care ophthalmic center.METHODS: Review of in vitro sensitivities of all ocular isolates of P. aeruginosa between July 1991 and September 1998. In vitro resistance was defined as a minimum inhibitory concentration of 4 or more μg per ml. RESULTS: Nine of 423 ocular isolates of P. aeruginosa showed in vitro resistance to ciprofloxacin. From 1991 to 1994, 0.44% (1/227) of ocular isolates were resistant to ciprofloxacin, whereas from 1995 to 1998, 4.1% (8/196) of ocular isolates showed in vitro resistance (P = .014).CONCLUSIONS: Ciprofloxacin-resistant P. aeruginosa has been identified in recent clinical ocular specimens. Ciprofloxacin resistance among ocular isolates of P. aeruginosa is a local and worldwide concern. Copyright (C) 1999 Elsevier Science Inc.

AB - PURPOSE: To report a clinical series of ciprofloxacin-resistant ocular isolates of Pseudomonas aeruginosa from a tertiary care ophthalmic center.METHODS: Review of in vitro sensitivities of all ocular isolates of P. aeruginosa between July 1991 and September 1998. In vitro resistance was defined as a minimum inhibitory concentration of 4 or more μg per ml. RESULTS: Nine of 423 ocular isolates of P. aeruginosa showed in vitro resistance to ciprofloxacin. From 1991 to 1994, 0.44% (1/227) of ocular isolates were resistant to ciprofloxacin, whereas from 1995 to 1998, 4.1% (8/196) of ocular isolates showed in vitro resistance (P = .014).CONCLUSIONS: Ciprofloxacin-resistant P. aeruginosa has been identified in recent clinical ocular specimens. Ciprofloxacin resistance among ocular isolates of P. aeruginosa is a local and worldwide concern. Copyright (C) 1999 Elsevier Science Inc.

UR - http://www.scopus.com/inward/record.url?scp=0032880618&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0032880618&partnerID=8YFLogxK

U2 - 10.1016/S0002-9394(99)00196-8

DO - 10.1016/S0002-9394(99)00196-8

M3 - Article

C2 - 10577596

AN - SCOPUS:0032880618

VL - 128

SP - 509

EP - 510

JO - American Journal of Ophthalmology

JF - American Journal of Ophthalmology

SN - 0002-9394

IS - 4

ER -

Emerging ciprofloxacin-resistant Pseudomonas aeruginosa

Abstract

ASJC Scopus subject areas

Access to Document

Other files and links

Fingerprint

Cite this